Molgramostim biosimilar (Zhejiang Chinagene Biopharmaceutical)
莫拉司亭生物类似药（浙江中奇生物药业）
Report date: 2022/07/19 16:22:54
Base Information
Drug NameMolgramostim biosimilar (Zhejiang Chinagene Biopharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSuzhou Research Institute Institute Of Biochemistry And Cell Biology Chinese Academy Of Sciences
China Registration ClassN/A
Develop Information
Active CompaniesZhejiang Zhongqi Biological Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A